265 related articles for article (PubMed ID: 15491778)
1. Mast cells as targets of corticotropin-releasing factor and related peptides.
Theoharides TC; Donelan JM; Papadopoulou N; Cao J; Kempuraj D; Conti P
Trends Pharmacol Sci; 2004 Nov; 25(11):563-8. PubMed ID: 15491778
[TBL] [Abstract][Full Text] [Related]
2. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
[TBL] [Abstract][Full Text] [Related]
3. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
Singh LK; Pang X; Alexacos N; Letourneau R; Theoharides TC
Brain Behav Immun; 1999 Sep; 13(3):225-39. PubMed ID: 10469524
[TBL] [Abstract][Full Text] [Related]
4. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
[TBL] [Abstract][Full Text] [Related]
5. Mast cells and inflammation.
Theoharides TC; Alysandratos KD; Angelidou A; Delivanis DA; Sismanopoulos N; Zhang B; Asadi S; Vasiadi M; Weng Z; Miniati A; Kalogeromitros D
Biochim Biophys Acta; 2012 Jan; 1822(1):21-33. PubMed ID: 21185371
[TBL] [Abstract][Full Text] [Related]
6. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
7. Stress neuropeptides evoke epithelial responses via mast cell activation in the rat colon.
Santos J; Yates D; Guilarte M; Vicario M; Alonso C; Perdue MH
Psychoneuroendocrinology; 2008 Oct; 33(9):1248-56. PubMed ID: 18691825
[TBL] [Abstract][Full Text] [Related]
8. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
Zhou C; Yu X; Cai D; Liu C; Li C
Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells.
Kempuraj D; Papadopoulou NG; Lytinas M; Huang M; Kandere-Grzybowska K; Madhappan B; Boucher W; Christodoulou S; Athanassiou A; Theoharides TC
Endocrinology; 2004 Jan; 145(1):43-8. PubMed ID: 14576187
[TBL] [Abstract][Full Text] [Related]
10. The critical role of mast cells in allergy and inflammation.
Theoharides TC; Kalogeromitros D
Ann N Y Acad Sci; 2006 Nov; 1088():78-99. PubMed ID: 17192558
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats.
Kaneko K; Kawana S; Arai K; Shibasaki T
Exp Dermatol; 2003 Feb; 12(1):47-52. PubMed ID: 12631246
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor decreases IL-18 in the monocyte-derived dendritic cell.
Lee HJ; Kwon YS; Park CO; Oh SH; Lee JH; Wu WH; Chang NS; Lee MG; Lee KH
Exp Dermatol; 2009 Mar; 18(3):199-204. PubMed ID: 18803662
[TBL] [Abstract][Full Text] [Related]
13. Peripheral α-helical CRF (9-41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats.
van den Wijngaard RM; Stanisor OI; van Diest SA; Welting O; Wouters MM; de Jonge WJ; Boeckxstaens GE
Neurogastroenterol Motil; 2012 Mar; 24(3):274-82, e111. PubMed ID: 22129370
[TBL] [Abstract][Full Text] [Related]
14. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.
Cao J; Boucher W; Kempuraj D; Donelan JM; Theoharides TC
J Urol; 2006 Sep; 176(3):1208-13. PubMed ID: 16890727
[TBL] [Abstract][Full Text] [Related]
15. Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin.
Kempuraj D; Papadopoulou N; Stanford EJ; Christodoulou S; Madhappan B; Sant GR; Solage K; Adams T; Theoharides TC
Am J Reprod Immunol; 2004 Oct; 52(4):267-75. PubMed ID: 15494048
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
[TBL] [Abstract][Full Text] [Related]
17. Contribution of stress to asthma worsening through mast cell activation.
Theoharides TC; Enakuaa S; Sismanopoulos N; Asadi S; Papadimas EC; Angelidou A; Alysandratos KD
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):14-9. PubMed ID: 22727152
[TBL] [Abstract][Full Text] [Related]
18. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
[TBL] [Abstract][Full Text] [Related]
19. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay.
Barreau F; Cartier C; Leveque M; Ferrier L; Moriez R; Laroute V; Rosztoczy A; Fioramonti J; Bueno L
J Physiol; 2007 Apr; 580(Pt 1):347-56. PubMed ID: 17234701
[TBL] [Abstract][Full Text] [Related]
20. The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory Response.
Dermitzaki E; Venihaki M; Tsatsanis C; Gravanis A; Avgoustinaki PD; Liapakis G; Margioris AN
Curr Mol Pharmacol; 2018; 11(1):39-50. PubMed ID: 28103784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
